Medication info

Uritin Tablet (Ranitidine Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
Optus Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201505705 · Approved 2015.08.13

This product's status changed to Expired on 2025.08.13. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome
Who takes it
Adults · Children
Adult dose
(Tablets) 150, 300 mg (Oral solution) 75 mg/sachet Administer 150 mg of ranitidine orally twice daily, in the morning and at bedtime. Gastric and duodenal ulcers: Administer 150 mg of this medicine orally twice daily, or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 300 mg twice daily, in the morning and at bedtime. The same dosage regimen applies to combination therapy to prevent ulcers caused by administration of nonsteroidal anti-inflammatory drugs or the development of gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. Reflux esophagitis: Administer 150 mg of this medicine twice daily for 8 weeks, or 300 mg once daily at bedtime. The dose may be increased to 150 mg four times daily in patients with severe reflux esophagitis. Zollinger-Ellison syndrome: Start treatment with an initial dose of 150 mg of this medicine three times daily, and increase the dose as needed. In severe cases, up to 6 g per day may be administered as directed by a physician. For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injection; once oral administration is possible, switch to oral administration of 150 mg of this medicine twice daily. Premedication for anesthesia (prevention of Mendelson's syndrome): Administer 150 mg of this medicine 2 hours before induction of anesthesia. Administration of 150 mg on the evening before surgery is also recommended. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis: Administer 150 mg of this medicine once daily at bedtime. Hyperacidity, heartburn, acid regurgitation: In patients 12 years of age and older, administer 75 mg of this medicine orally twice daily (oral solution only). In patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the medicine; therefore, adjust the dosing schedule immediately after hemodialysis. The dose may be adjusted according to age and symptoms.
Child dose
For patients 8 ∼ 18 years of age, 150 mg per dose (2 mg per kg of body weight) may be administered up to twice daily.

Ingredients

Manufacturer
Optus Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers due to NSAID use
  • gastric mucosal erosions
  • gastric mucosal bleeding
  • gastric mucosal redness
  • gastric mucosal swelling
  • acute gastritis
  • acute exacerbation of chronic gastritis
View approved original text

This medication is effective for various conditions associated with gastric acid, including gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also used to prevent ulcers after surgery and gastric/duodenal ulcers caused by non-steroidal anti-inflammatory drug use. It helps improve damage to the gastric mucosa (erosions, bleeding, redness, swelling) during acute exacerbations of acute and chronic gastritis and is beneficial for treating upper gastrointestinal bleeding. This medication is effective in alleviating symptoms of heartburn and acid regurgitation due to excessive gastric acid. It is used in the treatment and symptom improvement of various gastrointestinal disorders.

How to take

Adult dose

(Tablets) 150, 300 mg (Oral solution) 75 mg/sachet Administer 150 mg of ranitidine orally twice daily, in the morning and at bedtime. Gastric and duodenal ulcers: Administer 150 mg of this medicine orally twice daily, or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 300 mg twice daily, in the morning and at bedtime. The same dosage regimen applies to combination therapy to prevent ulcers caused by administration of nonsteroidal anti-inflammatory drugs or the development of gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. Reflux esophagitis: Administer 150 mg of this medicine twice daily for 8 weeks, or 300 mg once daily at bedtime. The dose may be increased to 150 mg four times daily in patients with severe reflux esophagitis. Zollinger-Ellison syndrome: Start treatment with an initial dose of 150 mg of this medicine three times daily, and increase the dose as needed. In severe cases, up to 6 g per day may be administered as directed by a physician. For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injection; once oral administration is possible, switch to oral administration of 150 mg of this medicine twice daily. Premedication for anesthesia (prevention of Mendelson's syndrome): Administer 150 mg of this medicine 2 hours before induction of anesthesia. Administration of 150 mg on the evening before surgery is also recommended. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis: Administer 150 mg of this medicine once daily at bedtime. Hyperacidity, heartburn, acid regurgitation: In patients 12 years of age and older, administer 75 mg of this medicine orally twice daily (oral solution only). In patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the medicine; therefore, adjust the dosing schedule immediately after hemodialysis. The dose may be adjusted according to age and symptoms.

Child dose

For patients 8 ∼ 18 years of age, 150 mg per dose (2 mg per kg of body weight) may be administered up to twice daily.

Precautions

This medication should not be used in patients with hypersensitivity to any of the components of this medication. Also, it should not be administered to patients with a history of acute porphyria, as it may trigger acute attacks. In patients with reduced kidney function, the serum concentration of this drug may increase, so adjustment of dose or dosing interval is necessary. Patients with poor liver function should also use this drug cautiously. Patients with a history of hypersensitivity, older adults, and those taking non-steroidal anti-inflammatory drugs should be administered this drug carefully. Especially, since it may mask symptoms of gastric cancer, patients with gastric ulcers or middle-aged persons with recent dyspepsia should confirm malignancy before treatment. Patients with positive Helicobacter pylori gastric and duodenal ulcers require treatment to eradicate the bacteria. This medication may rarely cause hypersensitivity reactions such as anaphylactic shock, hives, angioedema, and rashes, and if any abnormal symptoms occur, usage should be discontinued immediately. Blood-related side effects such as agranulocytosis, leukopenia, and thrombocytopenia may rarely occur, so if symptoms such as fatigue, bleeding, or fever arise, a blood test should be performed. Liver dysfunction may occur, so if jaundice or elevated liver enzyme symptoms develop, treatment should be stopped. Cardiovascular symptoms such as arrhythmias, constipation, nausea, vomiting, abdominal pain, dizziness, drowsiness, and confusion may also occur rarely, so monitoring is necessary. Long-term use of this drug or its use in older adults, patients with chronic lung diseases, or diabetes may increase the risk of pneumonia, so caution is advised. If dizziness or drowsiness occurs, avoid driving or operating dangerous machinery. This medication can interact with other drugs, so particularly when taking anticoagulants, careful monitoring of blood coagulation status is required. Additionally, taking it with sucralfate may reduce absorption; thus, it is advisable to take them with at least a 2-hour interval. Women who are pregnant or may become pregnant, and breastfeeding women, should use this medication cautiously, only when necessary. Safety in children has not been sufficiently confirmed, so caution is needed in its use. Older adults may likely have decreased kidney function, necessitating dose adjustment. Regular blood tests and liver function tests are recommended while taking this medication, as well as kidney function tests. In case of overdose, treatment such as vomiting, gastric lavage, and possibly blood dialysis may be required. Keep this medication out of the reach of children and do not transfer it to another container for safety. This drug may reduce gastric acid secretion and promote bacterial growth in the gastrointestinal tract, so regular examinations including ophthalmological checks are necessary with long-term use.

Side effects

  • anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • elevated serum creatinine
Show 52 more
  • leukopenia
  • thrombocytopenia
  • bone marrow depression
  • aplastic anemia
  • refractory anemia
  • agranulocytosis
  • pancytopenia
  • acquired autoimmune hemolytic anemia
  • eosinophilia
  • hepatic dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • atrioventricular block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • convulsions
  • headache
  • heaviness in the head
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • altered consciousness
  • myotonic contractions
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light, so it should be stored in a container that blocks light. Additionally, to keep the medication safe, it is important to store it at room temperature, that is, between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.